The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are investigating reports and complaints of infant illness related to formula from Abbott’s facility in Sturgis, Michigan.
FDA said Monday that a child had taken Similac PM 60/40 prior to the Cronobacter sakazakii infection and death. The agency said the infection “could have been a contributing cause of death” for the child.
Abbott recalled the formula with batch code 27032K800 on Monday. The company said that none of the products distributed tested positive for the presence of Cronobacter sakazakii.
“We appreciate the trust parents have in us about high-quality and safe nutrition, and we will do whatever it takes to keep that trust,” Abbott said. know in a statement emailed to CNN on Monday.
Other Abbott products should not be used if the first two digits of the batch code are 22 to 37; code on K8, SH or Z2 container; and the expiration date is April 1, 2022 or later.
There have been four reports of Cronobacter sakazakii infection in infants and one complaint of Salmonella Newport infection associated with products from the Sturgis facility, FDA said. Each of the five infants was hospitalized and Cronobacter may have contributed to the deaths of two, the agency added.
“The recall does not include liquid formula products,” the FDA said. “Consumers should continue to use all products that are not subject to the recall.”
Cronobacter bacteria can cause severe, life-threatening infections or inflammation of the membranes that protect the brain and spine. According to FDA.
The reports come as the United States is facing a shortage of infant formula. Manufacturers say they are running at full capacity and are producing more formula than ever before, but still not enough to meet current demand.
The-CNN-Wire & Cable News Network, Inc., a WarnerMedia Company. Copyright Registered.
https://abc13.com/baby-formula-recall-infant-2022-similac-abbott-nutrition/11610584/ Baby formula recall 2022: More Similac infant formula recalled as CDC investigation expands